Apnimed, Inc. (APMD): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 16:45 ET
- Event date
- 2026-11-13
- Accession no.
- 0001193125-26-460864
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
Apnimed to restate financial statements over classification of $85.4 million gain
Apnimed said its financial statements for the three and six months ended June 30, 2026 should no longer be relied upon because a $85.4 million disposition gain was classified in continuing rather than discontinued operations. The correction does not affect total net income (loss), total net income (loss) per share or net cash flows. The company plans to restate the affected statements.
- On November 13, 2026, the Audit Committee concluded that the affected financial statements should no longer be relied upon.
- A $85.4 million gain was classified in continuing operations rather than discontinued operations.
- The correction does not affect total net income (loss), total net income (loss) per share or net cash flows.
- Apnimed intends to file a Form 10-Q/A amendment on November 13, 2026.
restatement
Items reported
- Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
The company or its auditor concluded that previously issued financial statements should no longer be relied on because of an error.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | apmd-20261113.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.